BN Business News
Add your company to Business Communicator →

Regulation & law · 24/07/2003

Manufacturer of Controlled Substances; Notice of Registration

The U.S. Drug Enforcement Administration (DEA) has published a notice of registration for a pharmaceutical company, announcing its intention to manufacture and distribute controlled substances, such as opioids and other prescription medications, in compliance with federal regulations.

Original source language: Federal Register — Justice DepartmentOpen original release →

Explore insights